Anika Therapeutics, Inc.
NASDAQ: ANIK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Stephen D. Griffin
- Employees
- 288
- Headquarters
- Bedford, United States
- IPO year
- 1993
- Market cap
- $196.0M
- Website
- https://www.anikatherapeutics.com
Loading ANIK…
Loading profile data…Frequently asked questions about ANIK
What does Anika Therapeutics, Inc. (ANIK) do?
Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologie...
Where does ANIK trade?
Anika Therapeutics, Inc. (ANIK) trades on the NASDAQ Global Select.
What sector is ANIK in?
Anika Therapeutics, Inc. (ANIK) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Anika Therapeutics, Inc.?
Stephen D. Griffin is the chief executive officer of Anika Therapeutics, Inc. (ANIK).
Where is Anika Therapeutics, Inc. headquartered?
Anika Therapeutics, Inc. is headquartered in United States.
Does ANIK pay a dividend?
Anika Therapeutics, Inc. (ANIK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ANIK go public?
Anika Therapeutics, Inc. (ANIK) completed its initial public offering in 1993.